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Background: O. stamineus is a medicinal herb with remarkable pharmacological properties. However, poor
solubility of the active principles limits its medicinal value. This study sought to prepare nano liposomes of OS
ethanolic extract in unpurified soybean phospholipids in order to improve its solubility and permeability. OS
liposomes were prepared by the conventional film method, and were characterized for solubility, entrapment
efficiency, Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), particle size and
zeta potential, release, absorption in everted rat intestinal sacs, and DPPH scavenging effect.
Results: OS liposomes showed substantial enhancement of extract’s solubility from 956 ± 34 to 3979 ± 139 μg/ml,
with entrapment efficiency of 66.2 ± 0.9%. FTIR study indicates interaction between soybean phospholipids and OS
extract. TEM and dynamic light scattering showed presence of round anionic nano liposomes with particle size
and zeta potential of 152.5 ± 1.1 nm and −49.8 ± 1.0 mV, respectively. A study using the fluorescent probe
pyrene showed the critical micellar concentration is 9.2 ± 2.9 μg/ml. Release studies showed 94 ± 0.1% release in
non-formulated extract and 62.4 ± 0.1% in OS liposomes. Released extract from OS liposomes showed improvement
in DPPH scavenging effect, IC50 = 23.5 ± 1.1 μg/ml compared to 32.4 ± 0.5 μg/ml in non-formulated extract. OS
liposomes were stable at pH 5.5 and 7.4, but showed reversible agglomeration at pH 1.6. Absorption in everted rat
intestinal sacs showed substantial improvement in permeability of 3′-hydroxy-5, 6, 7, 4″-tetramethoxyflavone,
sinensetin, eupatorin, and 3 other unknown compounds.
Conclusions: Enhanced solubility, absorption and antioxidant effect may improve the overall pharmacological
effects and medicinal value of OS ethanolic extract.
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Orthosiphon stamineus Benth. (Lamiaceae) is a medicinal
herb widely distributed in Southeast Asia. Leaves of this
plant are commonly used in Southeast Asia and Europe as
herbal tea. OS is used as a traditional medicine for treat-
ment of some angiogenesis- related diseases such as
rheumatism, tumorous edema, obesity, diabetic retino-
pathy and psoriasis [1]. Research on OS has increased re-
cently due to its various pharmacological properties such
as diuretic and hypouricemic [2], hepatoprotective [3],* Correspondence: zhari@usm.my
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reproduction in any medium, provided the oranti-hyperglycemic [4], antioxidant and antimicrobial
[5-7], antiapoptotic [8], antiangiogenic and anticancer
effects [1]. Pharmacological effects of OS are attributed to
presence of polyphenolics, glycosides, lipophilic flavones
[9], rosmarinic acid (RA) and caffeic acid derivatives,
triterpenes [10], and diterpens [11-13]. The lipophilic
flavones of OS including sinensetin (SIN), eupatorin
(EUP) and 3′-hydroxy-5, 6, 7, 4′-tetramethoxyflavone
(TMF) (Figure 1) have been given considerable interest as
markers of pharmacological activity by several researchers
[1,9,14]. However; these lipophilic compounds suffer poor
aqueous solubility which limits the OS oral bioavailability
and therapeutic applications. The OS ethanolic extract is
rich in the lipophilic flavones such as EUP, SIN and TMF
while containing very low concentration of proteins andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Chemical structure of 3′-hydroxy-5, 6, 7, 4′-
tetramethoxyflavone (TMF), sinensetin (SIN) and eupatorin (EUP).
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lipophilic flavones may improve the bioavailability and
hence the overall pharmacological activity of OS extracts.
Liposomes are artificial vesicles formed by one or more
concentric lipid bilayers separated by water compartments
[15]. They have a unique ability of encapsulating hydro-
phobic, hydrophilic and amphiphilic compounds [16,17].
Drugs with varying hydrophobicities can be encapsulated
in the phospholipid bilayer, in the entrapped aqueous core,
or at the bilayer interface [18]. Liposomal drug delivery
systems have several advantages such as improving
solubility, bioavailability and efficacy, reduced toxicity,
and increased product stability and patient compliance
[15,16,18]. Phospholipids from soybean lecithin are widely
used in liposomal drug delivery systems due to their
safety, and wide availability at relatively low cost for up-
scale production. Crude soybean lecithin contains 65–75%
phospholipids, together with triglycerides and smaller
amounts of other substances such as carbohydrates, pig-
ments, sterols and sterol glycosides [19]. The major phos-
pholipids in soybean lecithin are phosphatidylcholine
(PC), phosphatidylethanolamine (PE), and phosphatidy-
linositol (PI) [20]. Liposomes of herbal extracts or isolated
compounds are usually prepared in pure phospholipids
[21,22], or in crude phospholipid extracts [17,23]. How-
ever, the cost of pure phospholipids is a limiting factor in
upscale production of liposomal drug delivery systems
particularly those containing herbal extracts or dietary
supplements [24]. It was estimated that one kilogram of
pure natural phospholipids costs around 980 Euro [17],
whereas the cost of crude soybean phospholipids is only
5% of the pure one, which makes unpurified soybean
phospholipids a good alternative and attractive choice.
This study sought to produce a cost effective nano
liposomes of OS ethanolic extract in crude soybeanphospholipids obtained from food grade soybean lecithin,
in order to improve the extract’s solubility and perme-
ability as major factors for improving oral bioavailability.
The liposomes were prepared by the film method and
were evaluated for solubility, entrapment efficiency,
stability under various pH conditions, critical micellar
concentration, particle size and zeta potential, FTIR spec-
troscopy, TEM, drug release, absorption through everted
rat’s small intestinal sacs, and free radical scavenging
effect.
Results and discussion
Analysis of soybean phospholipids and OS extract
The crude soybean lecithin was found to contain 62 ±
0.2% acetone insoluble phosphatides, and HPLC analysis
indicates phosphatidylcholine (PC) is the main phospho-
lipid ingredient in the phospholipids prepared (Figure 2).
The percentage of PC (based on peak area) in crude soy-
bean phospholipids, soybean phospholipid extract pre-
pared in ethanol (PH-Et), soybean phospholipid extract
prepared in acetone (PH-Ac), and phospholipid fraction
prepared by column chromatography (PH-Fr) was 13.4%,
21.6%, 10.6% and 42%, respectively.
Phytochemical analysis of OS extract revealed presence
of high content of phenolics (26%) and glycosaponins
(17%). UV–vis spectrum showed maximum absorption at
326 and 286 nm (Figure 3), and HPLC analysis (Figure 4)
revealed presence of RA (2.2%), EUP (1.7%), SIN (0.23%)
and TMF (0.1%).
Optimization of preparation method
Selection of phospholipids to extract ratio
The optimum phospholipids to extract ratio was selected
based on the improvement in aqueous solubility of OS
extract. At first, the formulations were prepared using
PH-Et phospholipid extract at various w/w ratios with
OS extract. Solubility of nonformulated OS extract (OS-E)
was determined by UV–vis spectrophotometry and was
found to be 956 ± 34 μg/ml. The formulations were pre-
pared by mixing ethanolic solution of the extract with
chloroform solution of phospholipids followed by eva-
poration of solvents and hydration of the resulting film.
Aqueous solubility results showed significant improve-
ment in formulations prepared at phospholipid: extract
ratio of 50:50, 150:50 and 100:50 (Table 1). The formu-
lation prepared at 100:50 w/w ratio showed the highest
improvement in solubility; therefore this formulation
was selected for further optimization.
Selection of solvent to dissolve the OS extract
At the beginning ethanol was selected to dissolve the
extract since OS ethanolic extract is used in this study.
However, solubility results of formulated extract were not
very encouraging. Therefore, methanol was used to
Figure 2 HPLC chromatograms of different types of soybean phospholipids. Crude soybean phospholipids (A), soybean phospholipid extract
prepared in ethanol (PH-Et) (B), soybean phospholipid extract prepared in acetone (PH-Ac) (C), and phospholipid fraction prepared by column
chromatography (PH-Fr) (D).
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substantial improvement of OS extract from 1402 ± 66 μg/
ml (ethanol) to 3979 ± 139 μg/ml (methanol) (P = 0.000). A
possible explanation of these results is that chloroform
evaporates (boiling point 61.2°C) at higher rate than
ethanol (bp, 78.4°C), leaving behind an ethanolic solution
of the extract and causing precipitation of phospholipids,
leading to phase separation and the formation of a non-
homogeneous mixture of extract and phospholipids. On
the other hand, chloroform and methanol evaporate at
almost the same rate due to the narrow difference between
their bp (bp of methanol = 65°C) leaving behind a homoge-
neous film of the extract and phospholipids. Consequently,
this made the water dispersion of the mixture much easier
and lead to substantial improvement in solubility.Selection of phospholipids extract
Three formulation types were prepared in 3 phospholipid
extracts including PH-Et, PH-Ac, and PH-Fr. The formula-
tions were prepared at phospholipid: extract ratio of 100:50,
and using methanol to dissolve the extract. Aqueous solu-
bility was determined by UV–vis spectrophotometry, and
the highest solubility (3862 ± 155 μg/ml) was obtained in
the formulation prepared in PH-Et phospholipid extract.
Formulation prepared in PH-Ac phospholipid extract
showed a solubility of 2997 ± 367 μg/ml, and the lowest
solubility was obtained when PH-Fr phospholipid fraction
(highest in PC content) was used (2082 ± 62 μg/ml)
(P = 0.000). Therefore, the final formulation was prepared
in PH-Et phospholipid extract that was used in all subse-
quent analysis.
Figure 3 UV–vis spectrophotometry of various formulations of OS ethanolic extract prepared in soybean phospholipids. The OS-E extract
showed maximum absorption at 286 nm and 326 nm in both formulated and non-formulated extract. OS-E refers to ethanolic extract, SBP refers to
soybean phospholipid, and F1-F5 refers to different formulations prepared at the following phospholipids to extract (mg/mg) ratios: 150/50, 100/50,
50/50, 25/50 and 25/75, respectively. (A) refers to absorbance.
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HPLC analysis of 4 marker compounds and 4 unknown
compounds revealed significant improvement in their
aqueous solubility compared to that obtained in non-
formulated extract (P values = 0.000, Student’s t-test)
(Table 2).
Fourier transform infrared spectroscopy
FTIR spectra of soybean phospholipid, OS extract, and OS
liposomes were studied in order to get insights into occur-
rence of interaction between OS extract and phospho-
lipids (Figure 5). In PH-Et phospholipids extract the broad
band centered at 3387 cm−1 represents the OH stretching,
the principal bands at 2854 cm−1 and 2924 cm−1 corres-
pond to the symmetric and anti-symmetric stretching in
the CH2 groups of alkyl chains, the strong band centered
at 1741 cm−1 corresponds to the stretching vibrations ofFigure 4 HPLC chromatograms of OS ethanolic extract in formulated
TMF, EUP and SIN; the solubility of these compounds are improved significan
OS-E refers to O. stamineus extract, and OS-L refers to O. stamineus liposomes
methoxyflavone, sinensetin and eupatorin, respectively.the ester carbonyl groups, the band centered at 1650 cm−1
is assigned to C =O stretching, and the scissoring vibra-
tions of the CH2 groups are represented by the band at
1465 cm−1. The characteristic phosphate group vibrational
band assigned to the PO2− anti-symmetric stretching
mode is centered at 1232 cm−1 and the PO2− symmetric
stretching mode PO2− at 1075 cm
−1 , these results are
similar to previously reported results [25]. In OS extract,
the broad band centered at 3385 cm−1 corresponds to OH
stretching, vibrations at 2924 cm−1 and 2854 cm−1 corres-
pond to C-H stretching, the bands centered at 1695 cm−1
and 1607 cm−1 correspond to stretching vibrations of car-
bonyl groups, the bands at 1600–1420 cm−1 correspond
to phenyl groups, the bands at 1267 cm−1 corresponds to
ester carbonyl groups, and the band at 1060 cm−1 corre-
sponds to primary OH groups. These results are consis-
tent with previous reports [26].and non-formulated forms. The chromatograms show presence of RA,
tly in the formulated OS extract compared to non-formulated extract.
. RA, TMF, SIN and EUP refer to rosmarinic acid, 3′-hydroxy-5, 6, 7, 4′-tetra-
Table 1 Aqueous solubility of various OS liposomes
No. PH-Et (mg) OS-E (mg) Solubility (μg/ml) P value
F1 150.0 50.0 1296.5 ± 18 0.000
F2 100.0 50.0 1401.7 ± 66 0.000
F3 50.0 50.0 1188.8 ± 169 0.001
F4 25.0 50.0 1018.8 ± 15 0.526
F5 25.0 75.0 1072.6 ± 6 0.084
Results are shown as AV ± SD, and the P value was calculated by One way
ANOVA with Dunnett’s Post Hoc test versus extract’s solubility in water (n = 3).
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absorption spectra as a result of incorporation of OS ex-
tract in phospholipids; the broad band corresponding to
OH groups is shifted from 3387 cm−1 to 3421 cm−1, the
C =O bands at 1695 cm−1 and 1607 cm−1 disappeared,
the band corresponding to C =O stretching in phospho-
lipids is shifted from 1650 cm−1 to 1634 cm−1, the band at
1267 cm−1 is shifted to lower frequency (1225 cm−1) with
much lower oscillation strength, the band at 1232 cm−1
disappeared, and band at 1075 cm−1 is shifted to 1071 cm−1.
The most pronounced spectral changes can be observed
in the spectral region corresponding to the polar heads of
phospholipids. Such changes may represent hydrogen
bonding between the polar heads of phospholipids with
the hydroxyl groups in OS extract. Hydrogen bonding can
also occur between the keto groups of flavonoids and oxy-
gen groups of phospholipids. Hydrophobic interaction
may also occur between the flavone’s methoxy groups and
the phospholipid tails.
Effect of pH on stability of liposomes
Stability of the OS liposomes at pH 1.6, 5.5 and 7.4 was
studied in order to predict their stability in the gastro-
intestinal tract. Agglomeration and precipitation of OS
liposomes occurred immediately after mixing with PBS
at pH 1.6, but not at pH 5.5, or 7.4 or water. The per-
centage of the soluble fraction (stable), relative to that in
water, was 66 ± 1.0% (pH 1.6), 94 ± 1.0% (pH 5.5) and
93 ± 3.0% (pH 7.4). These results indicate that OSTable 2 HPLC analysis of 4 marker and 4 unknown
compounds in OS extract (OS-E), and OS liposomes (OS-L)
Compounds RT (min) OS-E (mAU) OS-L (mAU)
RA 5.3 ± 0.01 301.5 ± 1.3 1933.9 ± 7.7
TMF 10.2 ± 0.03 10.1 ± 1.7 67.5 ± 0.4
SIN 12.7 ± 0.02 49.5 ± 1.4 254.8 ± 1.0
EUP 15.7 ± 0.03 19.1 ± 1.6 148.8 ± 19.9
5 9.6 ± 0.01 10.4 ± 1.3 85.8 ± 0.8
6 17.6 ± 0.07 13.0 ± 1.3 194.5 ± 0.4
7 18.2 ± 0.08 14.8 ± 1.2 223.4 ± 16.0
8 20.1 ± 0.05 18.1 ± 0.1 145.5 ± 25.9
Results are shown as average peak area (mAU) ± SD (n = 3).liposomes are highly stable at pH 5.5 and 7.4, but rela-
tively unstable at pH 1.6.
In order to verify whether the agglomeration observed
at pH 1.6 is reversible, the precipitate obtained at this
pH was re-dispersed in PBS at pH 1.6, 5.5 and 7.4. The
precipitate was totally dissolved at pH 5.5 and 7.4 but
not at pH 1.6. These findings indicate that the agglome-
ration observed at pH 1.6 is reversible at pH 5.5 and 7.4.
Under GIT pH, the OS liposomes are expected to
agglomerate under gastric conditions and re-dissolve
under intestinal pH. It is noteworthy that soybean phos-
pholipids and OS extract separately did not show any
precipitate at pH 1.6.
Entrapment efficiency
OS liposomes are unstable at pH 1.6, a property which
was used to study the entrapment efficiency of OS lipo-
somes. Entrapment efficiency was found to be 66.2 ± 0.9%
(n = 3). This value is considered satisfactory when com-
pared to published data on liposomal drug delivery sys-
tems of herbal extracts or compounds from herbal origin
[15]. Entrapment efficiency of RA, TMF, SIN and EUP
was 54.1 ± 0.2%, 28.2 ± 0.2%, 43 ± 0.2% and 38.3 ± 5.1%
respectively. The average entrapment efficiency (EE) of
the known fraction is almost 41%, as measured by HPLC.
The known fraction of the extract (including TMF, RA,
EUP and SIN) is only 4% of the total components, and the
exact EE of the unknown fraction is unknown and cannot
be measured accurately (theoretically, it can be higher
than 66% for some compounds and lower for others).
These two points may help to explain the difference in EE
observed. Basically, the lipophilic compounds have poor
solubility in water, and they have higher tendency to be
entrapped in the lipid bilayers of liposomes. Whereas the
hydrophilic drugs may be entrapped inside the aqueous
cores of liposomes, or located in the external water phase
[16]. It is noteworthy that the unentrapped extract can be
removed by centrifugation after acid treatment of the lipo-
somes, or by dialysis method without pretreatment, or can
be kept in the formulation. In this study the free extract
was kept in the formulation in order to avoid extract loss,
and reduce the production expanses.
The n-octanol: water partition
When a mixture of hydrophilic and hydrophobic com-
pounds is partitioned between n-octanol and water, the
hydrophilic compounds are distributed in water and the
hydrophobic compounds are concentrated in n-octanol
layer. Since OS liposomes have improved the extract’s
solubility, it is expected that the OS extract will be more
concentrated in the aqueous layer. Our results show that
40 ± 1.0% of the non-formulated extract is distributed in
the aqueous layer which indicates relatively low hydro-
philicity of the OS extract. On the other hand, this ratio
Figure 5 FTIR spectra of O. stamineus ethanolic extract (OS-E),
soybean phospholipids (SBP), and liposomes (OS-L). Remarkable
changes can be seen in the infrared absorption spectra due to
incorporation of OS extract in phospholipids; the broad band
corresponding to OH groups is shifted from 3387 cm−1 to 3421 cm−1,
the C =O bands at 1695 cm−1 and 1607 cm−1 disappeared, the band
corresponding to C =O stretching in phospholipids is shifted from
1650 cm−1 to 1634 cm−1, the band at 1267 cm−1 is shifted to 1225 cm−1,
the band at 1232 cm−1 disappeared, and band at 1075 cm−1 is shifted
to 1071 cm−1.
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tion, which indicates increased extract’s hydrophilicity.
Particle size analysis and transmission electron
microscopy (TEM)
Particle size measurement by Photon Correlation Spectros-
copy (PCS) indicates presence of structures with dynamic
diameter of 153–177 nm with narrow size distribution.
Zeta potential measurements showed presence of anionic
liposomes with a surface charge from −40 to −49 mV
(Table 3). The presence and morphology of liposomes were
further confirmed by TEM which verified the presence of
round liposomes of <200 nm. Furthermore, the lipid
bilayer of the OS liposomes can be seen clearly at high
magnification (Figure 6).
Critical micellar concentration
The critical micellar concentration (CMC) was deter-
mined using the fluorescent probe pyrene. The results
showed that addition of pyrene to aqueous solution
containing OS liposomes caused substantial quenchingTable 3 Analysis of particle size and zeta potential by PCS
Items Particle diameter (nm) Intensity (%) Count ra
SBP 177.2 ± 1.2 100.0 ± 0.1 543.8
OS-L 152.5 ± 1.1 99.0 ± 1.7 307.0
Results are displayed as AV ± SD (n = 3).of pyrene’s fluorescence in a dose dependent manner
(Figure 7A). Increasing liposomes concentration also
caused a redshift in emission intensity, and the intensity
ratio I384/I375 of pyrene was increased accordingly. The
CMC was estimated from the graph (Figure 7B) and was
found to be 9.2 ± 2.9 μg/ml.
In vitro release and antioxidant effect
Despite of the immediate dissolution of OS liposomes in
water, the percentage cumulative release was 62% after
24 h at 37°C and pH 6.8. On the other hand, the per-
centage cumulative release of non-formulated extract
under the same conditions was 94% (Figure 8). This re-
sult gives more insights into stability of the liposomal
structures under the test conditions, most likely due to
the interaction between OS extract and the phospholipid
carrier, and consequently leading slow release of the ac-
tive principles. The released extract was then studied for
DPPH scavenging effect. The results showed potent
scavenging of DPPH in both OS liposomes and non-for-
mulated extract; however with stronger effect obtained
in OS liposomes (IC50 = 23.5 ± 1.1 μg/ml) than in non-
formulated extract (IC50 = 32.4 ± 0.5 μg/ml), P = 0.000.
Absorption through everted intestinal sacs
Absorption studies were carried out using everted rat
small intestinal sacs under physiologic conditions (Tyr-
odes solution, pH 7.4 and 37°C and aeration). Intestinal
sacs were recovered after 1 h incubation, and the con-
tents were analyzed by HPLC. Significant improvement
in absorption of 7 compounds was achieved, with a
minor reduction in absorption of rosmarinic acid (RA).
The largest improvement was obtained in eupatorin
(EUP) which showed 9.8 ± 0.60 folds increment in the
compound’s absorption (Table 4). These results indicate
higher intestinal permeability of liposomal extract than
non-formulated extract, which can be explained due
to encapsulation in phospholipids, increased solubility,
presence of nanoscale liposomes, increased negativity
and colloidal stability [27]. Previous research on anionic
liposomes has shown enhancement of colloidal stability
and absorption [23], and even with higher cellular up-
take rate than neutral and cationic liposomes [28,29].
Conclusions
Collectively, the data presented in this study provide
evidence about feasibility of using unpurified soybean
phospholipids for preparation of nano liposomes of O.te (Kcps) Polydispersity index (PdI) Zeta potential (mV)
± 2.8 0.236 ± 0.004 −40.0 ± 2.2
± 17.3 0.233 ± 0.011 −49.8 ± 1.0
Figure 6 Morphology and particle size analysis of the OS liposomes. Transmission Electron Microscopy (TEM) photograph of OS liposomes
(A) and their lipid bilayer (B), particle size distribution (C), and zeta potential distribution (D). This figure confirms the presence of round
liposomes with narrow size distribution (<200 nm) and a negative surface charge.
Figure 7 Dose dependent quenching of pyrene fluorescence in
OS liposomes. Addition of pyrene to aqueous solution containing OS
liposomes caused substantial quenching of pyrene’s fluorescence in a
dose dependent manner (A); increasing liposomes concentration
caused a redshift in emission intensity and increased the I384/I375
intensity ratio (B). The critical micellar concentration (CMC) is estimated
from graph B and was found to be 9.2 ± 2.9 μg/ml.
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strated significant enhancement of intestinal absorption of
the active principles, which can be attributed to the
improvement in aqueous solubility and permeability, pre-
sence of nanoscale anionic liposomes, and colloidal stabil-
ity of OS liposomes. The sustained release profile along
with the improvement in free radical scavenging effectFigure 8 Percentage cumulative release of OS liposomes (OS-L)
and OS non-formulated extract (OS-E) at pH 6.8 and 37°C after
24 h. Concentration of released extract was determined by UV–vis
spectrophotometry. The percentage cumulative release in
non-formulated extract was 94% and reduced to 62% in the
formulated extract.
Table 4 Absorption through everted intestinal sacs after
1 h incubation
Compounds RT (min) OS-L/OS-E ratio
Unknown 1 4.9 ± 0.04 3.0 ± 0.40
RA 5.3 ± 0.06 0.9 ± 0.01
TMF 10.0 ± 0.16 4.0 ± 0.70
SIN 12.3 ± 0.22 2.3 ± 0.20
EUP 15.2 ± 0.32 9.8 ± 0.60
Unknown 2 17.6 ± 0.37 3.6 ± 0.10
Unknown 3 19.4 ± 0.44 3.4 ± 0.20
Results are presented as the AV ± SD of absorption ratio of OS liposomes
(OS-L) to non-formulated extract (OS-E) (n = 3–4).
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dative stress related diseases. Therefore, this study may
provide a basic formulation of Orthosiphon stamineus
ethanolic extract for preparation of oral drug delivery sys-
tem, and possibly topical delivery systems to the skin.Methods
Preparation and standardization of O. stamineus ethanolic
extract
OS dried leaves were obtained from specialized supplier
of herbal products in Malaysia (Herbagus Trading,
Kepala Batas, Pulau Pinang). OS ethanolic extract was
prepared by the maceration method as the following;
100 g of OS powder was added to 1 L of 96% ethanol,
mixed continuously on a magnetic stirrer for 48 h, filtered,
concentrated at 60°C by rotavapor and further freeze-
dried to 10.6 g of solid material. Total glycosaponins con-
tent of the extract was analyzed as previously described
[30], and total phenolics content was estimated as pre-
viously described by Aisha et al., [31]. Concentration of 4
marker compounds including rosmarinic acid (RA), sinen-
setin (SIN), eupatorin (EUP), and 3′-hydroxy-5,6,7,4′-
tetramethoxyflavone (TMF) was determined by reverse
phase HPLC as previously described [14]; analysis was
carried out using Agilent 1100 HPLC system, using
Nucleosil C18 column (250 mm× 4.6 mm, 5 μm), column
temperature was 25°C, injection volume was 20 μl, the
mobile phase was isocratic which consisted of methanol
(55%): tetrahydrofuran (5%): 0.1% H3PO4 (40%). Flow rate
was 0.7 ml/min, separation time 25 min, and wavelength
was 330 nm.
UV–vis spectrophotometry was carried out in the
wavelength range 500–200 nm using Perkin Elmer UV
spectrophotometer.Preparation of soybean phospholipids
The unpurified soybean phospholipids were prepared
from food grade soybean lecithin as previously described
with minor modifications [32]. In brief; crude lecithin(500 g) was refluxed in 96% ethanol (2.5 L) for 30 min and
cooled to RT. Subsequently, the supernatant was collected
by decantation and concentrated at 60°C using rotavapor.
The residue was then washed 5× with acetone (1 L) to
give 50 g of semi solid material; this phospholipid was
called PH-Et. In another experiment, 500 g of the food
grade lecithin was refluxed for 30 min in acetone (2.5 L),
cooled down to RT, and the precipitate was saved and fur-
ther washed with acetone (5×) to give 220 g and named
PH-Ac. In addition, a fraction containing higher concen-
tration of phosphatidylcholine was prepared as mentioned
previously [32]; this phospholipid fraction was named
PH-Fr.
The crude lecithin was characterized by measuring con-
centration of the acetone insoluble phosphatides and by
RP-HPLC [20,32]. The soybean phospholipid fractions
were analyzed by RP-HPLC as previously described with
some modifications [32]; Agilent 1100 HPLC system was
used, and separation was achieved on Agilent Eclipse C18
column (250 mm× 4.6 mm, 5 μm) at 35°C, the mobile
phase was isocratic which consisted of isopropyl alcohol,
methanol and water (70:22:8 v/v) at 0.5 ml/min. The sam-
ples were prepared in methanol at 1 mg/ml and filtered
through 0.45-μm syringe filter, injection volume was 10 μl,
and detection was done at 205 nm.
Preparation of OS liposomes
Liposomes of OS extract (OS-L) were prepared by the
film method as the following; soybean phospholipids
was dissolved in chloroform and OS extract was dis-
solved in ethanol or methanol, the solutions were mixed,
and the solvent was evaporated under vacuum using
rotary evaporator at 45°C for 30 min, followed by drying
in oven at 60°C for 1 h.
Determination of aqueous solubility
Solubility was evaluated by UV–vis spectrophotometry;
OS extract, and OS liposomes were dissolved at theo-
retical concentration of 4 mg/ml in deionized water, vor-
texed for 2 min, and sonicated for 10 min. Subsequently,
the solutions were centrifuged at 8000 rpm and 25°C for
10 min. Concentration of OS extract in the supernatant
was determined at 286 nm. A calibration curve was pre-
pared at the same time in order to calculate concen-
tration of soluble OS extract (y = 0.0135x – 0.0423,
R2 = 0.9999). All experiments were carried out in tri-
plicates. Concentration of 4 marker and 4 unknown
compounds was also determined by HPLC as described
previously.
Effect of pH on liposomes stability
Effect of pH on liposome’s stability was studied as pre-
viously described with some modifications [33]. OS lipo-
somes were dissolved in water at 4 mg/ml and further
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pH 1.6, 5.5, 7.4 and water, and incubated for overnight
(16 h) at 37°C. Subsequently, the solutions were centri-
fuged at 8000 rpm and 25°C for 10 min, and concentra-
tion of OS extract in the supernatant was determined by
UV spectrophotometry at 286 nm. The precipitate ob-
tained at pH 1.6 was resuspended in PBS (pH 1.6, 5.5
and 7.4), vortexed for 5 min, centrifuged, and the super-
natant was analyzed by UV spectrophotometry. The re-
sults are presented as percentage of soluble fraction
relative to liposomes diluted in water.Determination of entrapment efficiency
Entrapment efficiency was determined by precipitation of
OS liposomes at pH 1.6. It is noteworthy that this pH
caused precipitation of OS liposomes, but not the free ex-
tract. The OS liposomes was dissolved in water at 4 mg/ml,
sonicated for 10 min, and centrifuged at 8000 rpm for
10 min. The supernatant (1 ml) was added to the same
volume of PBS at pH 1.6, mixed thoroughly by vortex,
centrifuged at 8000 rpm for 10 min, the supernatant con-
taining the free extract was decanted, the precipitate was
washed with PBS (pH 1.6) and resuspended in 1 ml PBS
(pH 7.4). After sonication for 10 min, the extract content
was determined by UV spectrophotometry at 286 nm.
Concentration of RA, TMF, SIN and EUP was measured
by HPLC as described previously [14]. The entrapment ef-
ficiency was calculated as the following:
Entrapment efficiency ¼ ðconcentration in precipitate
=theoretical concentrationÞ
 100 n ¼ 3ð Þ:
Partition between n-octanol and water
OS extract and OS liposomes were prepared in deion-
ized water at 1 mg/ml and mixed with the same volume
of n-octanol. The mixtures were then mixed by several
manual inversions (30 times), allowed to settle for 4 h,
and centrifuged at 5000 rpm for 5 min to allow sepa-
ration of the 2 layers. Concentration of OS extract in
both layers was determined by UV–vis spectrophoto-
metry at 286 nm. The results are presented as the ratio
of extract concentration in aqueous phase relative to
that in n-octanol.Fourier transform infrared spectroscopy
FTIR analysis of OS extract, soybean phospholipids and
OS liposomes was carried out using Spectrum 400 spec-
trometer (Perkin Elmer, USA). The IR spectra were re-
corded in the range of 4000 – 400 cm−1 (n = 3).Measurement of particle size and zeta potential
Particle size, polydispersity index (PDI) and zeta potential
(ζ) were determined by Photon Correlation Spectroscopy
(PCS) using a Zetasizer nano zs (Malvern Instruments
Ltd, UK). The samples were dissolved in ultra pure water
(18 MΩ) at 1 mg/ml and filtered through 0.45-μm syringe
filters to remove any insoluble matter. Measurements
were carried out in triplicates.
Determination of critical micellar concentration
Critical micellar concentration (CMC) of OS liposomes
was estimated using the fluorescent probe pyrene [33].
Pyrene was dissolved in dimethylsulfoxide (DMSO) at
10 mM and diluted in PBS (pH 6.8) to 10 μM. Con-
centration of liposomes was maintained in the range
1–280 μg/ml in PBS. Pyrene was added at a final con-
centration of 0.1 μM and incubated for 30 min in the
dark at RT. Fluorescence intensity was measured at exci-
tation of 336 nm and emission of 375 and 384 nm by LS
45 fluorescence spectrometer (Perkin Elmer, USA). The
intensity ratio (I384/I375) was calculated and plotted
versus log concentration. The resulting curve was used
to calculate the CMC (n = 3).
Transmission electron microscopy
Studies in transmission electron microscopy (TEM) were
carried out in order to confirm presence of the liposo-
mal structures. One drop of OS liposomes (1 mg/ml in
water) was deposited on a 400 mesh copper grid coated
with 5 nm layer of carbon, air-dried at RT for 3 min, and
stained with 2% uranyl acetate for 1 min. The samples
were dried and studied using CM12 TEM (Philips,
Netherlands).
In vitro release and DPPH scavenging effect
In vitro release study was performed by dialysis method
using dialysis bags with molecular weight cut off value
8200 Dalton. The experiment was carried out using mag-
netic stirrer in PBS at pH 6.8, and 37°C with continuous
stirring at 100 rpm. Briefly, 10 ml of OS liposomes or
non-formulated OS extract (in water) containing 10 mg of
extract was filled in dialysis bag. The bags were herme-
tically sealed and kept in the receiver compartment con-
taining 200 ml of same medium. Samples (3 ml) were
collected at 0, 0.25, 0.5, 1.0, 2.0, 3.0, 6.0, 12, and 24 h, and
immediately replaced with 3 ml fresh medium. Concentra-
tion of extract was determined spectrophotometrically at
286 nm. The results are presented as average percentage
of cumulative release ± SD (n = 3). DPPH scavenging effect
of released extracts was then investigated as described
previously [31]; DPPH (9 mg/100 ml) was added to the
same volume of released extract, incubated at RT for
30 min, and absorbance was measured at 516 nm. Median
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the dose response curves (n = 3).
Absorption through the everted rat intestine
Absorption through everted rat intestinal sacs was carried
out as described previously with some modifications [27].
Overnight fasted male Sprague–Dawley rats were anesthe-
tized by diethyl ether and euthanized by cervical dislo-
cation. The first two thirds of the small intestine were
collected immediately after euthanasia, everted gently
using a glass rod, washed thoroughly, and were kept in
Tyrodes solution (NaCl, 8 g; KCl, 0.2 g; NaHCO3, 1 g;
CaCl2, 0.2 g; MgCl2.6H2O, 0.1 g; NaH2PO4, 0.05 g; and
glucose, 1 g dissolved in 1 L deionized water) at 37°C with
aeration. The tissues were cut into 6-cm length, sealed at
one end using surgical thread and filled with 1 ml aerated
Tyrodes solution. The intestinal sacs were kept for 1 h in a
medium containing OS liposomes or OS non-formulated
extract (120 μg/ml) in Tyrodes solution at 37°C with con-
tinuous agitation at 100 rpm using magnetic stirrer and
with continuous aeration with air. Subsequently, sacs were
removed, washed thoroughly from exterior with water, the
content was collected and centrifuged at 10000 rpm for
5 min, and the supernatant was analyzed by HPLC [14].
Peak area of the marker compounds was recorded, and the
fold change in absorption was calculated by dividing peak
area of compounds in OS liposomes by that of non-
formulated extract (n = 3–4).
Animals
Male Sprague–Dawley rats were obtained from USM ani-
mal breeding facility, and were allowed to acclimatize for
one week before the experiment. Experiment was per-
formed according to the guidelines of USM Animal Ethics
Committee (Ref. No.: USM/Animal Ethics Approval/
2012/ (78) (399)).
Statistical analysis
Results are presented as average ± SD of triplicate exper-
iments unless otherwise mentioned. Differences between
groups were considered significant at P < 0.05 using Stu-
dent’s t-test or One way ANOVA.
Abbreviations
OS: Orthosiphon stamineus; FTIR: Fourier transform infrared spectroscopy;
TEM: Transmission electron microscopy; DPPH: 2,2-Diphenyl-1-picrylhydrazyl;
RA: Rosmarinic acid; SIN: Sinensetin; EUP: Eupatorin; TMF: 3′-hydroxy-5,6,7,
4′-tetramethoxyflavone; PC: Phosphatidylcholine; PI: Phosphatidylinositol;
PE: Phosphatidylethanolamine; PH-Et: Soybean phospholipid extract prepared
in ethanol; PH-Ac: Soybean phospholipid extract prepared in acetone;
PH-Fr: Phospholipid fraction prepared by column chromatography;
UV–vis: Ultraviolet–visible; RP-HPLC: Reverse phase high performance liquid
chromatography; PBS: Phosphate buffered saline; OS-E: Orthosiphon
stamineus ethanolic extract; OS-L: Orthosiphon stamineus liposomes;
PCS: Photon correlation spectroscopy; CMC: Critical micellar concentration;
PDI: Polydispersity index; RT: Room temperature; SD: Standard deviation;
IC50: Median inhibitory concentration.Competing interests
The authors declare that no competing interests exist.
Authors’ contributions
AFAA developed the concept, designed and carried out experimental work,
analyzed the results, and prepared the manuscript. ZI and AMSAM
developed the concept and revised the manuscript in its final version. All
authors read and approved the final manuscript.
Acknowledgements
This project was funded by the Malaysian Ministry of Agriculture and
Agro-Based Industry, NKEA Research Grant Scheme (NRGS), Ref. No.: 304/
PFRMASI/650582/K123.
Author details
1Department of Pharmaceutical Chemistry, School of Pharmaceutical
Sciences, Universiti Sains Malaysia (USM), Minden 11800, Pulau Pinang,
Malaysia. 2Department of Pharmacology, School of Pharmaceutical Sciences,
Universiti Sains Malaysia (USM), Minden 11800, Pulau Pinang, Malaysia.
3Department of Pharmacy, School of Medicine and Health Sciences, An
Najah National University, Nablus, West Bank, Palestine.
Received: 3 March 2013 Accepted: 17 March 2014
Published: 27 March 2014
References
1. Ahamed MBK, Aisha AFA, Nassar ZD, Siddiqui JM, Ismail Z, Omari S, Parish C,
Majid AMSA: Cat’s whiskers tea (Orthosiphon stamineus) extract inhibits
growth of colon tumor in nude mice and angiogenesis in endothelial
cells via suppressing VEGFR phosphorylation. Nutr Cancer 2012, 64:89–99.
2. Arafat OM, Tham SY, Sadikun A, Zhari I, Haughton PJ, Asmawi MZ: Studies
on diuretic and hypouricemic effects of orthosiphon stamineus
methanol extracts in rats. J Ethnopharmacol 2008, 118:354–360.
3. Alshawsh MA, Abdulla MA, Ismail S, Amin ZA: Hepatoprotective effects of
orthosiphon stamineus extract on thioacetamide-induced liver cirrhosis
in rats. Evid Based Complement Altern Med 2011, 2011: Article ID 103039,
6 pages http://dx.doi.org/10.1155/2011/103039.
4. Mohamed EAH, Mohamed AJ, Asmawi MZ, Sadikun A, Ebrika OS, Yam MF:
Antihyperglycemic effect of orthosiphon stamineus benth leaves extract
and its bioassay-guided fractions. Molecules 2011, 16:3787–3801.
5. Ho C-H, Noryati I, Sulaiman S-F, Rosma A: In vitro antibacterial and
antioxidant activities of orthosiphon stamineus benth. Extracts against
food-borne bacteria. Food Chem 2010, 122:1168–1172.
6. Alshawsh MA, Abdulla MA, Ismail S, Amin ZA, Qader SW, Hadi HA, Harmal NS:
Free radical scavenging, antimicrobial and immunomodulatory activities of
orthosiphon stamineus. Molecules 2012, 17:5385–5395.
7. Hossain MA, Ismail Z, Rahman A, Kang SC: Chemical composition and
anti-fungal properties of the essential oils and crude extracts of
orthosiphon stamineus benth. Ind Crop Prod 2008, 27:328–334.
8. Abdelwahab SI, Mohan S, Mohamed Elhassan M, Al-Mekhlafi N, Mariod AA,
Abdul AB, Abdulla MA, Alkharfy KM: Antiapoptotic and antioxidant
properties of orthosiphon stamineus benth (cat’s whiskers): intervention
in the Bcl-2-mediated apoptotic pathway. Evid-Based Complement Altern
Med 2011, 156765. doi:10.1155/2011/156765.
9. Akowuah GA, Zhari I, Norhayati I, Sadikun A, Khamsah SM: Sinensetin,
eupatorin, 3′-hydroxy-5, 6, 7, 4′-tetramethoxyflavone and rosmarinic acid
contents and antioxidative effect of orthosiphon stamineus from
Malaysia. Food Chem 2004, 87:559–566.
10. Hossain MA, Mizanur Rahman SM: Isolation and characterisation of
flavonoids from the leaves of medicinal plant orthosiphon stamineus.
Arabian J Chem 2011. Article in press.
11. Takeda Y, Matsumoto T, Terao H, Shingu T, Futatsuishi Y, Nohara T, Kajimoto T:
Orthosiphol D and E, minor diterpenes from orthosiphon stamineus.
Phytochemistry 1993, 33:411–415.
12. Awale S, Tezuka Y, Banskota AH, Kouda K, Tun KM, Kadota S: Five novel
highly oxygenated diterpenes of orthosiphon s tamineus from Myanmar.
J Nat Prod 2001, 64:592–596.
13. Awale S, Tezuka Y, Banskota AH, Shimoji S, Taira K, Kadota S: Norstaminane-
and isopimarane-type diterpenes of orthosiphon stamineus from
Okinawa. Tetrahedron 2002, 58:5503–5512.
Aisha et al. BMC Biotechnology 2014, 14:23 Page 11 of 11
http://www.biomedcentral.com/1472-6750/14/2314. Siddiqui MJA, Ismail Z: Simultaneous analysis of bioactive markers from
orthosiphon stamineus benth leaves extracts by reverse phase high
performance liquid chromatography. Tropical Journal of Pharmaceutical
Research 2011, 10:97–103.
15. Munin A, Edwards-Lévy F: Encapsulation of natural polyphenolic
compounds; a review. Pharm 2011, 3:793–829.
16. Fang Z, Bhandari B: Encapsulation of polyphenols–a review. Trends Food
Sci Technol 2010, 21:510–523.
17. Yokota D, Moraes M, Pinho S: Characterization of lyophilized liposomes
produced with non-purified soy lecithin: a case study of casein
hydrolysate microencapsulation. Braz J Chem Eng 2012, 29:325–335.
18. Goyal P, Goyal K, Kumar SGV, Singh A, O.M.P K, Mishra DN: Liposomal drug
delivery systems-clinical applications. Acta Pharm 2005, 55:1–25.
19. Scholfield C: Composition of soybean lecithin. J Am Oil Chem Soc 1981,
58:889–892.
20. van Nieuwenhuyzen W, Tomás MC: Update on vegetable lecithin and
phospholipid technologies. Eur J Lipid Sci Technol 2008, 110:472–486.
21. Gortzi O, Lala S, Chinou I, Tsaknis J: Evaluation of the antimicrobial and
antioxidant activities of Origanum dictamnus extracts before and after
encapsulation in liposomes. Molecules 2007, 12:932–945.
22. Gortzi O, Lalas S, Chinou I, Tsaknis J: Reevaluation of bioactivity and
antioxidant activity of myrtus communis extract before and after
encapsulation in liposomes. Eur Food Res Technol 2008, 226:583–590.
23. Gülseren I, Guri A, Corredig M: Encapsulation of Tea polyphenols in
nanoliposomes prepared with milk phospholipids and their effect on the
viability of HT-29 human carcinoma cells. Food Digestion 2012, 3:36–45.
24. Taylor TM, Weiss J, Davidson PM, Bruce BD: Liposomal nanocapsules in
food science and agriculture. Crit Rev Food Sci Nutr 2005, 45:587–605.
25. Pawlikowska-Pawlęga B, Misiak LE, Zarzyka B, Paduch R, Gawron A,
Gruszecki WI: Localization and interaction of genistein with model
membranes formed with dipalmitoylphosphatidylcholine (DPPC).
Biochimica et Biophysica Acta (BBA)-Biomembranes 2012, 1818:1785–1793.
26. Sim CO, Hamdan MR, Ismail Z, Ahmad MN: Assessment of Herbal
Medicines by Chemometrics–Assisted Interpretation of FTIR Spectra.
J Analytica Chimica Acta 2004,1–14.
27. Guan S, Qin X, Zhou Z, Zhang Q, Huang Y: Investigation of the
mechanisms of improved oral bioavailability of bergenin using
bergenin-phospholipid complex. Drug Development and Industrial
Pharmacy 2013, 40:163–171.
28. Bajoria R, Sooranna SR, Contractor SF: Endocytotic uptake of small
unilamellar liposomes by human trophoblast cells in culture. Hum Reprod
1997, 12:1343–1348.
29. Ogiso T, Yamaguchi T, Iwaki M, Tanino T, Miyake Y: Effect of positively and
negatively charged liposomes on skin permeation of drugs. J Drug Target
2001, 9:49–59.
30. Siddiqui M, Hafizoh S, Ismail Z, Sahib H, Helal M: Analysis of total proteins,
polysaccharides and glycosaponins contents of orthosiphon stamineus
benth. in spray and freeze dried methanol: water (1: 1) extract and its
contribution to cytotoxic and antiangiogenic activities. Pharmacognosy
Research 2009, 1:320.
31. Aisha AF, Abu-Salah KM, Alrokayan SA, Ismail Z, Abdulmajid AM: Evaluation
of antiangiogenic and antoxidant properties of parkia speciosa hassk
extracts. Pak J Pharm Sci 2012, 25:7–14.
32. Patil VV, Galge RV, Thorat BN: Extraction and purification of
phosphatidylcholine from soyabean lecithin. Sep Purif Technol 2010,
75:138–144.
33. Aisha AF, Ismail Z, Abu-Salah KM, Majid AM: Solid dispersions of alpha-
mangostin improve its aqueous solubility through self-assembly of
nanomicelles. J Pharm Sci 2012, 101:815–825.
doi:10.1186/1472-6750-14-23
Cite this article as: Aisha et al.: Preparation and characterization of nano
liposomes of Orthosiphon stamineus ethanolic extract in soybean
phospholipids. BMC Biotechnology 2014 14:23.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
